Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05861 | 33097932 | J Nutr | Soy Food Intake Is Inversely Associated with Newly Diagnosed Nonalcoholic Fatty Liver Disease in the TCLSIH Cohort Study. | 2020 | Details |
| A05863 | 33096235 | J Nutr Biochem | Nobiletin alleviates high-fat diet-induced nonalcoholic fatty liver disease by modulating AdipoR1 and gp91phox expression in rats. | 2020 | Details |
| A05864 | 33096115 | Life Sci | The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer. | 2020 | Details |
| A05866 | 33096076 | Metabolism | Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeability. | 2020 | Details |
| A05873 | 33093014 | Diabetes | ETV5 Regulates Hepatic Fatty Acid Metabolism Through PPAR Signaling Pathway. | 2020 | Details |
| A05909 | 33078906 | FASEB J | Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism. | 2020 | Details |
| A05923 | 33075504 | Diabetes Metab | Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study. | 2020 | Details |
| A05927 | 33073044 | Transl Gastroenterol Hepatol | Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease. | 2020 | Details |
| A05933 | 33071981 | Front Endocrinol (Lausanne) | Carotid Extra-Media Thickness in Children: Relationships With Cardiometabolic Risk Factors and Endothelial Function. | 2020 | Details |
| A05946 | 33067533 | Sci Rep | HFD-induced hepatic lipid accumulation and inflammation are decreased in Factor D deficient mouse. | 2020 | Details |
| A05947 | 33066497 | J Pers Med | Genetic Ablation of MiR-22 Fosters Diet-Induced Obesity and NAFLD Development. | 2020 | Details |
| A05952 | 33064664 | Endocr Connect | The hepatic lipidome and HNF4α and SHBG expression in human liver. | 2020 | Details |
| A05953 | 33064150 | J Clin Endocrinol Metab | The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients. | 2021 | Details |
| A05954 | 33063664 | Elife | Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver. | 2020 | Details |
| A05958 | 33061754 | Turk Pediatri Ars | The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity. | 2020 | Details |
| A05959 | 33061687 | Hepat Med | Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review. | 2020 | Details |
| A05964 | 33060043 | Dig Liver Dis | Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD. | 2020 | Details |
| A05972 | 33057854 | Curr Diab Rep | Tissue-Specific Fructose Metabolism in Obesity and Diabetes. | 2020 | Details |
| A05976 | 33053981 | Zhonghua Gan Zang Bing Za Zhi | [Physical activity intervention for non-alcoholic fatty liver disease in children]. | 2020 | Details |
| A05986 | 33050482 | Int J Mol Sci | Early Pro-Inflammatory Remodeling of HDL Proteome in a Model of Diet-Induced Obesity: 2H2O-Metabolic Labeling-Based Kinetic Approach. | 2020 | Details |
| A05997 | 33045675 | J Trace Elem Med Biol | A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial. | 2020 | Details |
| A06003 | 33040692 | Trop Doct | Effects of anthropometric and metabolic parameters on transaminase levels and liver stiffness in patients with non-alcohol fatty liver disease. | 2020 | Details |
| A06020 | 33037249 | Sci Rep | Pathophysiology of high fat diet induced obesity: impact of probiotic banana juice on obesity associated complications and hepatosteatosis. | 2020 | Details |
| A06034 | 33033564 | World J Hepatol | Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases. | 2020 | Details |
| A06038 | 33032263 | J Endocrinol | Lactobacillus pentosus strain S-PT84 improves steatohepatitis by maintaining gut permeability. | 2020 | Details |
| A06040 | 33031969 | Ann Hepatol | Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures. | 2020 | Details |
| A06049 | 33028338 | Lipids Health Dis | The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. | 2020 | Details |
| A06058 | 33025629 | NMR Biomed | In vivo absolute quantification of hepatic γ-ATP concentration in mice using 31 P MRS at 11.7 T. | 2020 | Details |
| A06074 | 33015726 | Curr Diab Rep | Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06081 | 33013688 | Front Endocrinol (Lausanne) | Abdominal Adiposity and Total Body Fat as Predictors of Cardiometabolic Health in Children and Adolescents With Obesity. | 2020 | Details |
| A06089 | 33010471 | Mol Metab | Dysregulated lipid metabolism links NAFLD to cardiovascular disease. | 2020 | Details |
| A06097 | 33008924 | J Lipid Res | Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition. | 2020 | Details |
| A06099 | 33007695 | Food Chem | Polyphenols of cambuci (Campomanesia phaea (O. Berg.)) fruit ameliorate insulin resistance and hepatic steatosis in obese mice. | 2020 | Details |
| A06109 | 33004402 | BMJ Open Diabetes Res Care | Metabolic and energetic benefits of microRNA-22 inhibition. | 2020 | Details |
| A06112 | 33002297 | Mol Nutr Food Res | Huangjinya Black Tea Alleviates Obesity and Insulin Resistance via Modulating Fecal Metabolome in High-Fat Diet-Fed Mice. | 2020 | Details |
| A06113 | 33002003 | PLoS One | REV-ERB agonism improves liver pathology in a mouse model of NASH. | 2020 | Details |
| A06122 | 32998095 | Diabetes Metab Syndr | Pathophysiological mechanisms underlying MAFLD. | 2020 | Details |
| A06130 | 32994765 | Postepy Dermatol Alergol | Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications. | 2019 | Details |
| A06139 | 32992082 | Phytomedicine | Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse. | 2020 | Details |
| A06140 | 32991990 | J Steroid Biochem Mol Biol | Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndrome. | 2020 | Details |
| A06144 | 32990607 | Asia Pac J Clin Nutr | Impact of a low-carbohydrate and high-fiber diet on nonalcoholic fatty liver disease. | 2020 | Details |
| A06155 | 32984791 | JHEP Rep | Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. | 2020 | Details |
| A06156 | 32984364 | Front Med (Lausanne) | Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases. | 2020 | Details |
| A06165 | 32981283 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | [Effects of liraglutide combined with vitamin D on non-alcoholic fatty liver induced by high fat in mice and its mechanism]. | 2020 | Details |
| A06172 | 32979184 | Obes Surg | Prevalence and Factors Associated with Hepatic Iron Overload in Obese Individuals Undergoing Bariatric Surgery: a Cross-Sectional Study. | 2020 | Details |
| A06178 | 32978491 | Sci Rep | FIB-4 index is a marker for a subsequent decrease in insulin secretion in a non-diabetic Japanese population. | 2020 | Details |
| A06182 | 32977558 | Molecules | Distinct Influence of Hypercaloric Diets Predominant with Fat or Fat and Sucrose on Adipose Tissue and Liver Inflammation in Mice. | 2020 | Details |
| A06184 | 32977263 | J Affect Disord | Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation. | 2020 | Details |
| A06195 | 32973925 | Therap Adv Gastroenterol | The role of the gut microbiome and exercise in non-alcoholic fatty liver disease. | 2020 | Details |
| A06196 | 32973715 | Front Microbiol | Constant Light Exposure Alters Gut Microbiota and Promotes the Progression of Steatohepatitis in High Fat Diet Rats. | 2020 | Details |
| A06210 | 32966467 | Food Funct | Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. | 2020 | Details |
| A06218 | 32964054 | J Diabetes Res | Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients. | 2020 | Details |
| A06219 | 32963741 | Iran J Basic Med Sci | The role of acylated ghrelin and unacylated ghrelin in the blood and hypothalamus and their interaction with nonalcoholic fatty liver disease. | 2020 | Details |
| A06220 | 32963510 | PPAR Res | Diet Modifies Pioglitazone's Influence on Hepatic PPARγ-Regulated Mitochondrial Gene Expression. | 2020 | Details |
| A06227 | 32961669 | Nutrients | Effects of Dietary and Lifestyle Interventions on Liver, Clinical and Metabolic Parameters in Children and Adolescents with Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2020 | Details |
| A06228 | 32961610 | J Diabetes Investig | Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus. | 2020 | Details |
| A06232 | 32961235 | Life Sci | Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice. | 2020 | Details |
| A06235 | 32959866 | Food Funct | Two polyphenol-rich Brazilian fruit extracts protect from diet-induced obesity and hepatic steatosis in mice. | 2020 | Details |
| A06238 | 32958032 | Orphanet J Rare Dis | Consensus clinical management guidelines for Alström syndrome. | 2020 | Details |
| A06243 | 32953932 | Mol Ther Methods Clin Dev | Soluble Klotho Improves Hepatic Glucose and Lipid Homeostasis in Type 2 Diabetes. | 2020 | Details |
| A06251 | 32952340 | World J Gastroenterol | Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice. | 2020 | Details |
| A06255 | 32951743 | Complement Ther Med | Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. | 2020 | Details |
| A06256 | 32951715 | Complement Ther Med | The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial. | 2020 | Details |
| A06258 | 32951410 | Clin Mol Hepatol | Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases. | 2020 | Details |
| A06274 | 32945071 | Diabetes Obes Metab | A look to the future in non-alcoholic fatty liver disease: Are glucagon-like peptide-1 analogues or sodium-glucose co-transporter-2 inhibitors the answer? | 2020 | Details |
| A06279 | 32943747 | Sci Rep | Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects. | 2020 | Details |
| A06281 | 32943651 | Sci Rep | Punica granatum L.-derived omega-5 nanoemulsion improves hepatic steatosis in mice fed a high fat diet by increasing fatty acid utilization in hepatocytes. | 2020 | Details |
| A06284 | 32942044 | Cell Mol Gastroenterol Hepatol | Liver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner. | 2020 | Details |
| A06292 | 32939643 | Biol Trace Elem Res | Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver. | 2020 | Details |
| A06297 | 32937194 | Mol Metab | Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis. | 2020 | Details |
| A06300 | 32936098 | J R Coll Physicians Edinb | Diagnosis and management of fatty liver. | 2020 | Details |
| A06301 | 32936063 | J Am Coll Nutr | Correlating Circulating Vitamin D3 with Aspects of the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Healthy Female Volunteers. | 2020 | Details |
| A06305 | 32934691 | Exp Ther Med | Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review). | 2020 | Details |
| A06309 | 32933722 | Tissue Cell | Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats. | 2020 | Details |
| A06316 | 32932174 | J Trace Elem Med Biol | The effects of zinc supplementation on metabolic profile and oxidative stress in overweight/obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. | 2020 | Details |
| A06318 | 32931733 | Cell | Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output. | 2020 | Details |
| A06319 | 32930860 | Wien Klin Wochenschr | Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease. | 2020 | Details |
| A06340 | 32923108 | Am J Cardiovasc Dis | Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis. | 2020 | Details |
| A06347 | 32920973 | Mol Nutr Food Res | Dietary Rapeseed Oil Supplementation Reduces Hepatic Steatosis in Obese Men-A Randomized Controlled Trial. | 2020 | Details |
| A06354 | 32918763 | FASEB J | Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD. | 2020 | Details |
| A06360 | 32916379 | Nutrition | Pleiotropic ameliorative effects of ellagitannin geraniin against metabolic syndrome induced by high-fat diet in rats. | 2020 | Details |
| A06362 | 32916011 | Liver Transpl | Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis. | 2020 | Details |
| A06368 | 32910776 | Diabetes Care | Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes. | 2020 | Details |
| A06369 | 32910646 | J Med Chem | Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. | 2020 | Details |
| A06376 | 32907986 | J Lipid Res | Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice. | 2020 | Details |
| A06382 | 32905826 | Toxicology | Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro. | 2020 | Details |
| A06394 | 32896622 | Biochim Biophys Acta Mol Cell Biol Lipids | 12α-Hydroxylated bile acid induces hepatic steatosis with dysbiosis in rats. | 2020 | Details |
| A06403 | 32892365 | Aliment Pharmacol Ther | Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease. | 2020 | Details |
| A06405 | 32891697 | Biochimie | Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? | 2020 | Details |
| A06412 | 32888949 | Metabolism | Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice. | 2020 | Details |
| A06413 | 32888948 | Physiol Behav | The effect of aerobic, resistance, and combined training on PPAR-α, SIRT1 gene expression, and insulin resistance in high-fat diet-induced NAFLD male rats. | 2020 | Details |
| A06430 | 32883049 | Cells | A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology. | 2020 | Details |
| A06437 | 32881925 | PLoS One | Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance. | 2020 | Details |
| A06468 | 32868653 | Eur J Gastroenterol Hepatol | Predictive markers of nonalcoholic fatty liver disease in lean patients. A multinomial regression model and a 2k factorial analysis. | 2021 | Details |
| A06479 | 32863886 | BioData Min | Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease. | 2020 | Details |
| A06480 | 32863329 | Tohoku J Exp Med | Hybrid Training System Improves Insulin Resistance in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study. | 2020 | Details |
| A06485 | 32861753 | Gastrointest Endosc | Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty. | 2020 | Details |
| A06490 | 32857176 | Eur J Nutr | Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study. | 2020 | Details |
| A06491 | 32856978 | J Med Food | Fisetin Alleviates Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice. | 2020 | Details |
| A06501 | 32850903 | Front Med (Lausanne) | Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis. | 2020 | Details |